Liang Xiao1, Annet Kirabo1, Jing Wu1, Mohamed A Saleh1, Linjue Zhu1, Feng Wang1, Takamune Takahashi1, Roxana Loperena1, Jason D Foss1, Raymond L Mernaugh1, Wei Chen1, Jackson Roberts1, John W Osborn1, Hana A Itani1, David G Harrison2. 1. From the Department of Medicine, Divisions of Clinical Pharmacology (L.X., A.K., J.W., M.A.S., L.Z., W.C., J.R., H.A.I., D.G.H.) and Nephrology and Hypertension (T.T.), Departments of Radiology and Radiological Sciences (F.W.), Molecular Physiology and Biophysics (R.L.), and Biochemistry (R.L.M.), Vanderbilt University, Nashville, TN; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Dakahlia Governorate, Egypt (M.A.S.); and Department of Integrative Biology and Physiology, University of Minnesota, Minneapolis (J.D.F., J.W.O.). 2. From the Department of Medicine, Divisions of Clinical Pharmacology (L.X., A.K., J.W., M.A.S., L.Z., W.C., J.R., H.A.I., D.G.H.) and Nephrology and Hypertension (T.T.), Departments of Radiology and Radiological Sciences (F.W.), Molecular Physiology and Biophysics (R.L.), and Biochemistry (R.L.M.), Vanderbilt University, Nashville, TN; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Mansoura University, Mansoura, Dakahlia Governorate, Egypt (M.A.S.); and Department of Integrative Biology and Physiology, University of Minnesota, Minneapolis (J.D.F., J.W.O.). david.g.harrison@vanderbilt.edu.
Abstract
RATIONALE: Inflammation and adaptive immunity play a crucial role in the development of hypertension. Angiotensin II and probably other hypertensive stimuli activate the central nervous system and promote T-cell activation and end-organ damage in peripheral tissues. OBJECTIVE: To determine if renal sympathetic nerves mediate renal inflammation and T-cell activation in hypertension. METHODS AND RESULTS: Bilateral renal denervation using phenol application to the renal arteries reduced renal norepinephrine levels and blunted angiotensin II-induced hypertension. Bilateral renal denervation also reduced inflammation, as reflected by decreased accumulation of total leukocytes, T cells, and both CD4+ and CD8+ T cells in the kidney. This was associated with a marked reduction in renal fibrosis, albuminuria, and nephrinuria. Unilateral renal denervation, which partly attenuated blood pressure, only reduced inflammation in the denervated kidney, suggesting that this effect is pressure independent. Angiotensin II also increased immunogenic isoketal-protein adducts in renal dendritic cells (DCs) and increased surface expression of costimulation markers and production of interleukin (IL)-1α, IL-1β, and IL-6 from splenic DCs. Norepinephrine also dose dependently stimulated isoketal formation in cultured DCs. Adoptive transfer of splenic DCs from angiotensin II-treated mice primed T-cell activation and hypertension in recipient mice. Renal denervation prevented these effects of hypertension on DCs. In contrast to these beneficial effects of ablating all renal nerves, renal afferent disruption with capsaicin had no effect on blood pressure or renal inflammation. CONCLUSIONS: Renal sympathetic nerves contribute to DC activation, subsequent T-cell infiltration and end-organ damage in the kidney in the development of hypertension.
RATIONALE: Inflammation and adaptive immunity play a crucial role in the development of hypertension. Angiotensin II and probably other hypertensive stimuli activate the central nervous system and promote T-cell activation and end-organ damage in peripheral tissues. OBJECTIVE: To determine if renal sympathetic nerves mediate renal inflammation and T-cell activation in hypertension. METHODS AND RESULTS: Bilateral renal denervation using phenol application to the renal arteries reduced renal norepinephrine levels and blunted angiotensin II-induced hypertension. Bilateral renal denervation also reduced inflammation, as reflected by decreased accumulation of total leukocytes, T cells, and both CD4+ and CD8+ T cells in the kidney. This was associated with a marked reduction in renal fibrosis, albuminuria, and nephrinuria. Unilateral renal denervation, which partly attenuated blood pressure, only reduced inflammation in the denervated kidney, suggesting that this effect is pressure independent. Angiotensin II also increased immunogenic isoketal-protein adducts in renal dendritic cells (DCs) and increased surface expression of costimulation markers and production of interleukin (IL)-1α, IL-1β, and IL-6 from splenic DCs. Norepinephrine also dose dependently stimulated isoketal formation in cultured DCs. Adoptive transfer of splenic DCs from angiotensin II-treated mice primed T-cell activation and hypertension in recipient mice. Renal denervation prevented these effects of hypertension on DCs. In contrast to these beneficial effects of ablating all renal nerves, renal afferent disruption with capsaicin had no effect on blood pressure or renal inflammation. CONCLUSIONS: Renal sympathetic nerves contribute to DC activation, subsequent T-cell infiltration and end-organ damage in the kidney in the development of hypertension.
Authors: Anne Hamik; Zhiyong Lin; Ajay Kumar; Mercedes Balcells; Sumita Sinha; Jonathan Katz; Mark W Feinberg; Robert E Gerzsten; Elazer R Edelman; Mukesh K Jain Journal: J Biol Chem Date: 2007-03-05 Impact factor: 5.157
Authors: Daniel W Trott; Salim R Thabet; Annet Kirabo; Mohamed A Saleh; Hana Itani; Allison E Norlander; Jing Wu; Anna Goldstein; William J Arendshorst; Meena S Madhur; Wei Chen; Chung-I Li; Yu Shyr; David G Harrison Journal: Hypertension Date: 2014-08-04 Impact factor: 10.190
Authors: David E Kandzari; Deepak L Bhatt; Sandeep Brar; Chandan M Devireddy; Murray Esler; Martin Fahy; John M Flack; Barry T Katzen; Janice Lea; David P Lee; Martin B Leon; Adrian Ma; Joseph Massaro; Laura Mauri; Suzanne Oparil; William W O'Neill; Manesh R Patel; Krishna Rocha-Singh; Paul A Sobotka; Laura Svetkey; Raymond R Townsend; George L Bakris Journal: Eur Heart J Date: 2014-11-16 Impact factor: 29.983
Authors: Heinrich E Lob; Paul J Marvar; Tomasz J Guzik; Shraya Sharma; Louise A McCann; Cornelia Weyand; Frank J Gordon; David G Harrison Journal: Hypertension Date: 2009-12-14 Impact factor: 10.190
Authors: Annet Kirabo; Vanessa Fontana; Ana P C de Faria; Roxana Loperena; Cristi L Galindo; Jing Wu; Alfiya T Bikineyeva; Sergey Dikalov; Liang Xiao; Wei Chen; Mohamed A Saleh; Daniel W Trott; Hana A Itani; Antony Vinh; Venkataraman Amarnath; Kalyani Amarnath; Tomasz J Guzik; Kenneth E Bernstein; Xiao Z Shen; Yu Shyr; Sheau-chiann Chen; Raymond L Mernaugh; Cheryl L Laffer; Fernando Elijovich; Sean S Davies; Heitor Moreno; Meena S Madhur; Jackson Roberts; David G Harrison Journal: J Clin Invest Date: 2014-09-17 Impact factor: 14.808
Authors: Deepak L Bhatt; David E Kandzari; William W O'Neill; Ralph D'Agostino; John M Flack; Barry T Katzen; Martin B Leon; Minglei Liu; Laura Mauri; Manuela Negoita; Sidney A Cohen; Suzanne Oparil; Krishna Rocha-Singh; Raymond R Townsend; George L Bakris Journal: N Engl J Med Date: 2014-03-29 Impact factor: 91.245
Authors: Tomasz J Guzik; Nyssa E Hoch; Kathryn A Brown; Louise A McCann; Ayaz Rahman; Sergey Dikalov; Jorg Goronzy; Cornelia Weyand; David G Harrison Journal: J Exp Med Date: 2007-09-17 Impact factor: 14.307
Authors: Yi Wen; Nathan P Rudemiller; Jiandong Zhang; Xiaohan Lu; Jiafa Ren; Jamie R Privratsky; Robert Griffiths; Junyi J Zhang; Gianna E Hammer; Steven D Crowley Journal: Hypertension Date: 2020-01-27 Impact factor: 10.190
Authors: Nandita Raikwar; Cameron Braverman; Peter M Snyder; Robert A Fenton; David K Meyerholz; Francois M Abboud; Sailesh C Harwani Journal: Am J Physiol Heart Circ Physiol Date: 2019-06-07 Impact factor: 4.733
Authors: H P Yan; L J Roberts; S S Davies; P Pohlmann; F F Parl; S Estes; J Maeng; B Parker; R Mernaugh Journal: Free Radic Biol Med Date: 2017-02-09 Impact factor: 7.376
Authors: Niousha Ahmari; Monica M Santisteban; Douglas R Miller; Natalie M Geis; Riley Larkin; Ty Redler; Heather Denson; Habibeh Khoshbouei; David M Baekey; Mohan K Raizada; Jasenka Zubcevic Journal: Am J Physiol Heart Circ Physiol Date: 2019-05-31 Impact factor: 4.733
Authors: Christopher T Banek; Mark M Knuepfer; Jason D Foss; Jessica K Fiege; Ninitha Asirvatham-Jeyaraj; Dusty Van Helden; Yoji Shimizu; John W Osborn Journal: Hypertension Date: 2016-10-03 Impact factor: 10.190